Cargando…

LncRNA OIP5-AS1 modulates the proliferation and apoptosis of Jurkat cells by sponging miR-181c-5p to regulate IL-7 expression in myasthenia gravis

BACKGROUND: Myasthenia gravis (MG) is an antibody-mediated autoimmune disease. In recent years, accumulating evidence has indicated that long non-coding RNAs (lncRNAs) can function as competing endogenous RNAs (ceRNAs), contributing to the progression of various autoimmune diseases. Nevertheless, th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xu, Zhang, Huixue, Lu, Xiaoyu, Li, Shuang, Kong, Xiaotong, Liu, Li, Li, Lifang, Xu, Si, Wang, Tianfeng, Wang, Jianjian, Wang, Lihua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	PeerJ Inc. 2022
Materias:	Biochemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121865/ https://www.ncbi.nlm.nih.gov/pubmed/35602889 http://dx.doi.org/10.7717/peerj.13454

Ejemplares similares

Identification of the regulatory role of lncRNA HCG18 in myasthenia gravis by integrated bioinformatics and experimental analyses
por: Li, Shuang, et al.
Publicado: (2021)

Associations of BAFF rs2893321 polymorphisms with myasthenia gravis susceptibility
por: Deng, Hui, et al.
Publicado: (2019)

Competitive endogenous RNA network and pathway-based analysis of LncRNA single-nucleotide polymorphism in myasthenia gravis
por: Wang, Tianfeng, et al.
Publicado: (2021)

Identification of LINC00173 in Myasthenia Gravis by Integration Analysis of Aberrantly Methylated- Differentially Expressed Genes and ceRNA Networks
por: Xu, Si, et al.
Publicado: (2021)

Construction of an miRNA-regulated drug-pathway network reveals drug repurposing candidates for myasthenia gravis
por: Cao, Yuze, et al.
Publicado: (2017)

Building the drug-GO function network to screen significant candidate drugs for myasthenia gravis
por: Li, Shuang, et al.
Publicado: (2019)

Identification of the Regulatory Role of lncRNA SNHG16 in Myasthenia Gravis by Constructing a Competing Endogenous RNA Network
por: Wang, Jianjian, et al.
Publicado: (2020)

LncRNA LINC00680 Acts as a Competing Endogenous RNA and Is Associated With the Severity of Myasthennia Gravis
por: Liu, Li, et al.
Publicado: (2022)

Identifying a Polymorphic ‘Switch’ That Influences miRNAs' Regulation of a Myasthenia Gravis Risk Pathway
por: Yang, Lili, et al.
Publicado: (2014)

Construction of a TF–miRNA–gene feed-forward loop network predicts biomarkers and potential drugs for myasthenia gravis
por: Bo, Chunrui, et al.
Publicado: (2021)

Detecting Key Genes Regulated by miRNAs in Dysfunctional Crosstalk Pathway of Myasthenia Gravis
por: Cao, Yuze, et al.
Publicado: (2015)

miR-181a Ameliorates the Progression of Myasthenia Gravis by Regulating TRIM9
por: Wang, Qiang, et al.
Publicado: (2021)

Corrigendum to “Detecting Key Genes Regulated by miRNAs in Dysfunctional Crosstalk Pathway of Myasthenia Gravis”
por: Cao, Yuze, et al.
Publicado: (2017)

Inhibitory effect and mechanism of action (MOA) of hirsutine on the proliferation of T-cell leukemia Jurkat clone E6-1 cells
por: Meng, Jie, et al.
Publicado: (2021)

Response to: Comment on “Detecting Key Genes Regulated by miRNAs in Dysfunctional Crosstalk Pathway of Myasthenia Gravis”
por: Cao, Yuze, et al.
Publicado: (2017)

RNA2Immune: A Database of Experimentally Supported Data Linking Non-coding RNA Regulation to The Immune System
por: Wang, Jianjian, et al.
Publicado: (2023)

LncRNA OIP5-AS1/cyrano sponges RNA-binding protein HuR
por: Kim, Jiyoung, et al.
Publicado: (2016)

Extraocular Muscle Characteristics Related to Myasthenia Gravis Susceptibility
por: Liu, Rui, et al.
Publicado: (2013)

Long Noncoding RNA OIP5-AS1 Inhibits Cell Apoptosis and Cataract Formation by Blocking POLG Expression Under Oxidative Stress
por: Jing, Ruihua, et al.
Publicado: (2020)

Afterdischarges in Myasthenia Gravis
por: Yang, Li, et al.
Publicado: (2021)

Weiterer C5-Antikörper gegen Myasthenia gravis
por: Müller, Thomas
Publicado: (2022)

Retracted: miR-181a Ameliorates the Progression of Myasthenia Gravis by Regulating TRIM9
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Myasthenia gravis
por: Juel, Vern C, et al.
Publicado: (2007)

Myasthenia Gravis
por: Aarli, Johan A., et al.
Publicado: (2011)

Myasthenia Gravis
Publicado: (1905)

Myasthenia Gravis
por: Wilson, Andrew
Publicado: (1952)

Myasthenia Gravis
por: Bramwell, Edwin
Publicado: (1901)

A chromatin-associated splicing isoform of OIP5-AS1 acts in cis to regulate the OIP5 oncogene
por: Wanowska, Elżbieta, et al.
Publicado: (2021)

lncRNA OIP5-AS1 attenuates the osteoarthritis progression in IL-1β-stimulated chondrocytes
por: Zhang, Xuefeng, et al.
Publicado: (2023)

Linkage of lncRNA CRNDE sponging miR-181a-5p with aggravated inflammation underlying sepsis
por: Wang, Yijun, et al.
Publicado: (2019)

Immunotherapy choice and maintenance for generalized myasthenia gravis in China
por: Zhang, Chao, et al.
Publicado: (2020)

Circulating CXCR5 (+) natural killer cells are expanded in patients with myasthenia gravis
por: Ge, Meng‐Ru, et al.
Publicado: (2023)

O-5 Novel HLA II associations in myasthenia gravis
por: Massa, R., et al.
Publicado: (2011)

The role of OIP5 in the carcinogenesis and progression of ovarian cancer
por: Zhang, Xin, et al.
Publicado: (2023)

Favorable Effects of Tacrolimus Monotherapy on Myasthenia Gravis Patients
por: Fan, Zhirong, et al.
Publicado: (2020)

Editorial: Phenotypes of myasthenia gravis
por: Li, Hai-Feng, et al.
Publicado: (2022)

Immunopathogenesis in Myasthenia Gravis and Neuromyelitis Optica
por: Wang, Zhen, et al.
Publicado: (2017)

Interleukin-27 levels in patients with myasthenia gravis
por: Liu, Xiao-Jiao, et al.
Publicado: (2020)

Clinical predictors for the prognosis of myasthenia gravis
por: Wang, Lili, et al.
Publicado: (2017)

Thymectomy for myasthenia gravis
por: Moorehead, R J, et al.
Publicado: (1985)

Cannot write session to /tmp/vufind_sessions/sess_jt0gbus6eaho2te5pnh7ldhps1